Deal Snapshot: Bristol-Myers Squibb Closes Bid for Medarex

Summary


MANAVIGATOR-September 2, 2009-Deal snapshot: BRISTOL-MYERS SQUIBB CLOSES BID FOR MEDAREX (C)2010 M2 COMMUNICATIONS http://www.m2.com

US drug maker Bristol-Myers Squibb (NYSE:BMY) said that its cash tender offer for the acquisition of bio-pharmaceuticals maker Medarex (NASDAQ:MEDX) expired yesterday and the company now owned 90.7% in Medarex.

See the full content of this document

Extract


Deal Snapshot: Bristol-Myers Squibb Closes Bid for Medarex

Stat...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company